Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,434 | 561 | 55.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $4,000 | 2 | 21.3% |
| Travel and Lodging | $3,280 | 14 | 17.4% |
| Education | $610.95 | 11 | 3.3% |
| Honoraria | $472.90 | 1 | 2.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic USA, Inc. | $6,426 | 93 | $0 (2020) |
| PROCEPT BioRobotics Corporation | $2,408 | 21 | $0 (2024) |
| Astellas Pharma US Inc | $2,111 | 113 | $0 (2024) |
| Axonics, Inc. | $1,216 | 38 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $889.35 | 46 | $0 (2024) |
| NeoTract Inc. | $739.02 | 17 | $0 (2019) |
| ABBVIE INC. | $661.08 | 36 | $0 (2024) |
| PFIZER INC. | $585.06 | 31 | $0 (2024) |
| Antares Pharma, Inc. | $479.77 | 25 | $0 (2024) |
| Endo Pharmaceuticals Inc. | $370.28 | 19 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,022 | 76 | Sumitomo Pharma America, Inc. ($493.61) |
| 2023 | $3,926 | 113 | PROCEPT BioRobotics Corporation ($1,916) |
| 2022 | $1,873 | 97 | Axonics, Inc. ($318.08) |
| 2021 | $1,643 | 67 | Axonics, Inc. ($856.37) |
| 2020 | $292.64 | 14 | Astellas Pharma US Inc ($199.37) |
| 2019 | $2,813 | 98 | Medtronic USA, Inc. ($1,658) |
| 2018 | $1,133 | 68 | Astellas Pharma US Inc ($364.85) |
| 2017 | $5,095 | 56 | Medtronic USA, Inc. ($4,497) |
All Payment Transactions
589 individual payment records from CMS Open Payments — Page 1 of 24
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $22.18 | General |
| Category: UROLOGY | ||||||
| 12/03/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $19.36 | General |
| Category: UROLOGY | ||||||
| 12/01/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $25.82 | General |
| Category: ONCOLOGY | ||||||
| 11/21/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $26.05 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/20/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $21.79 | General |
| Category: UROLOGY | ||||||
| 11/17/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $24.50 | General |
| Category: ONCOLOGY | ||||||
| 11/06/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $26.15 | General |
| Category: UROLOGY | ||||||
| 11/05/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $20.11 | General |
| Category: Oncology | ||||||
| 10/29/2024 | Blue Earth Diagnostics Limited | POSLUMA (Drug) | Food and Beverage | In-kind items and services | $16.31 | General |
| Category: Diagnostic Imaging | ||||||
| 10/22/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: HORMONE THERAPY | ||||||
| 10/21/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $28.80 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/16/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $18.73 | General |
| Category: UROLOGY | ||||||
| 09/25/2024 | Blue Earth Diagnostics Limited | POSLUMA (Drug) | Food and Beverage | In-kind items and services | $18.29 | General |
| Category: Diagnostic Imaging | ||||||
| 09/24/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $21.01 | General |
| Category: HORMONE THERAPY | ||||||
| 09/18/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/17/2024 | Ambu Inc. | — | Food and Beverage | Cash or cash equivalent | $20.56 | General |
| 08/30/2024 | PROCEPT BioRobotics Corporation | AQUABEAM SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $148.32 | General |
| Category: UROLOGY | ||||||
| 08/28/2024 | Ambu Inc. | — | Food and Beverage | Cash or cash equivalent | $19.62 | General |
| 08/16/2024 | Innovation Technologies Inc | IRRISEPT (Device) | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: JET LAVAGE DEVICE WITH CHG | ||||||
| 08/14/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $25.77 | General |
| Category: UROLOGY | ||||||
| 08/13/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $21.94 | General |
| Category: Oncology | ||||||
| 08/13/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $20.25 | General |
| Category: HORMONE THERAPY | ||||||
| 08/06/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $30.03 | General |
| Category: UROTHELIAL CANCER | ||||||
| 08/05/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $25.50 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 07/30/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $20.65 | General |
| Category: UROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 30 | 2,723 | 4,137 | $1.1M | $301,629 |
| 2022 | 32 | 2,636 | 4,089 | $1.3M | $330,718 |
| 2021 | 37 | 3,636 | 5,373 | $1.4M | $422,090 |
| 2020 | 34 | 3,573 | 5,533 | $1.3M | $373,049 |
All Medicare Procedures & Services
136 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 682 | 1,011 | $253,761 | $88,833 | 35.0% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 37 | 325 | $279,175 | $43,425 | 15.6% |
| J3490 | Unclassified drugs | Office | 2023 | 20 | 64 | $57,600 | $33,242 | 57.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 458 | 514 | $86,866 | $33,019 | 38.0% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 118 | 150 | $83,700 | $28,188 | 33.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 157 | 157 | $61,387 | $18,854 | 30.7% |
| 64561 | Insertion of sacral nerve neurostimulator electrode array | Office | 2023 | 11 | 11 | $30,283 | $9,650 | 31.9% |
| 52356 | Crushing of stone of ureter with insertion of stent using an endoscope | Facility | 2023 | 25 | 29 | $30,131 | $8,924 | 29.6% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 274 | 325 | $21,775 | $5,857 | 26.9% |
| 11980 | Placement of hormone pellet under skin | Office | 2023 | 20 | 65 | $16,315 | $4,612 | 28.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 30 | 32 | $10,816 | $4,462 | 41.3% |
| 64561 | Insertion of sacral nerve neurostimulator electrode array | Facility | 2023 | 11 | 11 | $30,283 | $2,640 | 8.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 30 | 30 | $7,530 | $2,454 | 32.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 16 | 233 | $12,815 | $2,317 | 18.1% |
| 55700 | Biopsy of prostate gland | Facility | 2023 | 21 | 21 | $12,915 | $1,931 | 14.9% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 38 | 75 | $7,125 | $1,709 | 24.0% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 145 | 202 | $10,706 | $1,621 | 15.1% |
| 84403 | Testosterone (hormone) level, total | Office | 2023 | 49 | 62 | $5,704 | $1,568 | 27.5% |
| 64590 | Insertion of peripheral or gastric neurostimulator generator | Facility | 2023 | 15 | 15 | $11,250 | $1,280 | 11.4% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 12 | 12 | $4,344 | $1,166 | 26.8% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2023 | 11 | 21 | $4,305 | $1,011 | 23.5% |
| 74420 | Imaging of urinary tract following injection of a contrast agent | Facility | 2023 | 37 | 44 | $3,960 | $823.25 | 20.8% |
| 87086 | Bacterial colony count, urine | Office | 2023 | 69 | 101 | $2,929 | $791.91 | 27.0% |
| 81003 | Automated urinalysis test | Office | 2023 | 231 | 367 | $2,936 | $788.40 | 26.9% |
| 76872 | Ultrasound scan of pelvic region through rectum | Facility | 2023 | 21 | 21 | $7,602 | $504.08 | 6.6% |
About Dr. Eric Darby, M.D
Dr. Eric Darby, M.D is a Urology healthcare provider based in Newport News, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/27/2005. The National Provider Identifier (NPI) number assigned to this provider is 1104822865.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eric Darby, M.D has received a total of $18,797 in payments from pharmaceutical and medical device companies, with $2,022 received in 2024. These payments were reported across 589 transactions from 52 companies. The most common payment nature is "Food and Beverage" ($10,434).
As a Medicare-enrolled provider, Darby has provided services to 12,568 Medicare beneficiaries, totaling 19,132 services with total Medicare billing of $1.4M. Data is available for 4 years (2020–2023), covering 136 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location Newport News, VA
- Active Since 06/27/2005
- Last Updated 03/29/2021
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1104822865
Products in Payments
- INTERSTIM (Device) $4,426
- AQUABEAM ROBOTIC SYSTEM (Device) $1,916
- Axonics r-SNM System (Device) $849.51
- XTANDI (Drug) $831.07
- GEMTESA (Drug) $769.30
- UroLift (Device) $634.34
- Myrbetriq (Drug) $500.92
- AQUABEAM SYSTEM (Device) $491.41
- ORGOVYX (Drug) $421.87
- BOTOX (Biological) $401.89
- Xtandi (Drug) $377.98
- NOCDURNA (Drug) $375.93
- MYRBETRIQ (Drug) $361.26
- Axonics (Device) $359.99
- Nubeqa (Drug) $316.53
- XIAFLEX (Biological) $305.36
- LUPRON DEPOT (Drug) $203.00
- Axumin (Drug) $192.74
- Erleada (Drug) $142.49
- JELMYTO (Drug) $115.52
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Newport News
Geoffrey Kostiner, M.d, M.D
Urology — Payments: $25,464
Dr. Ifeanyichukwu Ani, M.d, M.D
Urology — Payments: $8,909
David Hartke, Md, MD
Urology — Payments: $5,091
Dr. John Mcgill, M.d, M.D
Urology — Payments: $4,236
Henry Prillaman, M.d, M.D
Urology — Payments: $2,868
Brianna Mchugh, Pa-C, PA-C
Urology — Payments: $974.59